Oncology

Product Name Product Description Specification
SL#004 Oncology Phenotypic Screening
Release: 04/14/2016

Deregulation of the balance between cell proliferation and death can lead to the formation of tumor malignancies. Signaling transduction pathways can regulate this process via the interaction of multiple functional extracellular and intracellular proteins such as kinases (e.g.

In library: Phenotypic Oncology
SL#015 Ser-Thr Kinases
Release: 05/12/2016

Approximately 125 of 500 human protein kinases are serine/threonine kinases (STK).

In library: Ser/Thr kinase inhibitors
SL#023 Oncology Phenotypic Screening. Colon Cancer
Release: 07/28/2016

Phenotypic screening is a firmly established technology that has contributed to the identification of valuable therapeutic agents for oncology drug discovery [1]. More specifically, in colon cancers multiple etiological pathways are responsible for disease onset and development [2].

In library: Phenotypic Oncology
SL#035 MTT Macrocycles
Release: 07/11/2016

Phenotypic screening is a firmly established technology that has contributed to the identification of valuable therapeutic agents in oncology drug discovery [1]. For example, in colon cancer multiple etiological pathways are responsible for disease onset and development [2]. 

In library: Phenotypic Oncology
SL#043 State1(T) inhibitors of activated Ras
Release: 08/08/2016
In library: GTPase inhibitors
SL#046 xGFR inhibitors
Release: 08/17/2016
In library: Growth factor receptors inhibitors